We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Critical Care

Burn Injury Reprograms Extracellular Vesicle Communication: Linking Immune Activation and Neuroinflammation

MedXY Editorial Team•Aug 4, 2026•Critical Care
inflammationburn injuryneuroimmune communicationextracellular vesicles

Highlight

Severe burn injury induces marked changes in the protein composition of plasma extracellular vesicles (EVs), reflecting enhanced inflammatory and neuroimmune signaling. Key proteins such as CRP and ITGA11 were significantly modulated, suggesting EV cargo remodeling aligns with the systemic hyperinflammatory response and neuronal pathway alterations. This study highlights the potential for EV-based biomarkers to improve diagnosis and guide therapeutic interventions in burn care.

Study Background

Burn injuries encompassing ≥15% total body surface area (TBSA) provoke a complex pathophysiological cascade characterized by systemic inflammation, metabolic derangement, and immune dysregulation. These responses collectively influence healing outcomes and risk of complications such as infection and organ dysfunction. Despite advances, mechanistic insights into the molecular intermediaries that regulate immune-neural cross-talk in burn trauma remain limited. Extracellular vesicles (EVs), submicron membrane-bound particles secreted by virtually all cell types, have emerged as pivotal mediators of intercellular communication, ferrying proteins, lipids, and nucleic acids to modulate recipient cell function. Investigating EV proteome alterations after burn injury provides a promising avenue to elucidate underlying pathways linking immune activation and neuronal signaling that may influence clinical trajectory.

Study Design

This observational study analyzed plasma EVs isolated from 37 adult burn patients with ≥15% TBSA burns and 21 matched nonburn controls. An age-restricted subcohort (patients <40 years) was examined to reduce age-related confounding effects. Among these, a subset (n=4 per group) underwent further separation of EVs enriched in immune cell and neuronal origins. Proteomic profiling employed mass spectrometry to detect protein abundance shifts, followed by functional enrichment analyses, including gene ontology (GO) over-representation analysis (ORA), Reactome gene set enrichment analysis (GSEA), and Ingenuity Pathway Analysis (IPA), to delineate pathway perturbations.

Key Findings

The proteomic analysis identified 919 proteins in plasma EVs, with 593 proteins increased and 326 decreased in burn patients compared to controls. The top five significantly discriminative proteins were C-reactive protein (CRP), integrin alpha-11 (ITGA11), myosin heavy chain 9 (MYH9), calreticulin (CALR), and anthrax toxin receptor 2 (ANTXR2), all statistically significant after adjustment.

Functional enrichment consistently revealed upregulation of immune activation and inflammation-related pathways, including immune cell chemotaxis, acute-phase response signaling, cytokine-mediated signaling pathways, complement cascade activation, coagulation system pathways, and cellular stress response mechanisms. Notably, similar pathway enrichment persisted in the younger subcohort, indicating the findings are robust across age groups.

Exploratory proteomic analyses of EV subtypes enriched for immune and neuronal origins demonstrated discrete trends suggesting coordinated remodeling of cell-type specific intercellular communication. Although no individual subtype-specific proteins reached statistical significance, the data imply complex neuroimmune interactions post burn injury.

Expert Commentary

This study elegantly underscores the integral role of EVs as conveyors of systemic inflammatory and neural signaling alterations after major burn trauma. The identification of prominent acute-phase proteins such as CRP within EV cargo emphasizes their potential as minimally invasive biomarkers reflective of systemic inflammation intensity. Additionally, the involvement of proteins linked to cellular adhesion (ITGA11) and stress responses (CALR) illustrates the multifaceted biological processes influenced by burn injury.

Mechanistically, EV-mediated neuroimmune communication may contribute to the maladaptive inflammatory states that challenge burn recovery, affecting both peripheral immune responses and central neuronal networks regulating pain, stress, and repair. Nonetheless, limitations include the relatively small sample size for cell-specific EV analyses and lack of longitudinal outcome correlation, warranting further validation in larger cohorts and functional studies to explore causality.

Conclusion

Burn injury induces a profound reprogramming of plasma extracellular vesicle protein cargo, reflecting enhanced inflammatory and neuroimmune signaling pathways fundamental to the burn pathophysiology. The coordinated modification of EV content across general, immune, and neuronal compartments supports their role as key mediators and potential biomarkers for immune-neural dysregulation after burns. Future efforts should aim to harness EVs for improved diagnostics and targeted therapies to modulate hyperinflammation and promote effective healing in burn patients.

Funding and Clinical Trials Registration

Details of funding sources and clinical trial registration were not specified in the current publication.

References

1. Grimsrud KN, Green T, Tang Y, et al. Burn Injury Rewires Immune and Neuronal Extracellular Vesicle Communication. Ann Surg. 2026 Jul 29. PMID: 42524719.
2. Fish JE, Ghaffari S, Belekanyama E, et al. Extracellular vesicles in burn trauma: immune regulation and therapeutic potential. J Burn Care Res. 2022;43(5):760-772.
3. Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010;73(10):1907-20.
4. Pitt JM, Charrier M, Viaud S, et al. Dendritic cell-derived exosomes for cancer therapy. J Clin Invest. 2016;126(4):1224-31.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Impact of Germline and Somatic DNMT3A Variants on Pulmonary Arterial Hypertension: A New Frontier in Biomarkers and TherapeuticsGermline and somatic variants in DNMT3A and other CHIP genes elevate pulmonary arterial hypertension risk, including connective tissue disease-associated forms, through pro-inflammatory pathways, highlighting novel biomarkers and therapeutiSep 8, 2026TP53-Mutated Clonal Hematopoiesis Drives Pro-Inflammatory Phenotype and Predicts Poor Outcomes After CAR T-Cell TherapyTP53-mutant clonal hematopoiesis in CAR T-cell recipients is linked to a pro-inflammatory state, cytopenias, and worse survival, highlighting the importance of tailored monitoring strategies in this high-risk group.Aug 26, 2026Semaglutide’s Impact on Inflammation and Cardiovascular Risk in Overweight Patients: Insights from the SELECT TrialIn the SELECT trial, semaglutide significantly lowered hsCRP levels and major cardiovascular events in patients with established atherosclerotic cardiovascular disease and overweight or obesity, suggesting inflammation reduction as a possibAug 21, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing &amp; care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
HIF2 Activation in Cardiac Vasculature: A Novel Mechanistic Insight into Kawasaki Disease’s Cardiovascular Complications
This study reveals how HIF2 activation drives coronary artery remodeling, inflammation, and thrombosis in a mouse model mirroring severe Kawasaki disease, uncovering new therapeutic targets for coronary complications.
Aug 18, 2026
Extracellular Vesicles as Liquid Biopsy Biomarkers Predicting Immune Checkpoint Therapy Resistance in Hepatocellular CarcinomaCirculating extracellular vesicles carrying PD-1, PD-L1, and CTLA-4 can non-invasively predict responses and early resistance to immune checkpoint inhibitors in advanced hepatocellular carcinoma, improving patient stratification and managemAug 9, 2026
Interleukin-6 as a Central Mediator of Therapeutic Success in Acute Lung Injury and COVID-19This article examines interleukin-6 (IL-6) as a key mediator of therapeutic efficacy in acute lung injury and COVID-19, highlighting its role in modulating inflammation and survival outcomes across multiple clinical interventions.Aug 6, 2026